NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?
NRx Pharmaceuticals Ownership Summary
NRx Pharmaceuticals is owned by 18.25% institutional investors, 15.88% insiders, and 65.87% retail investors. Anson funds management lp is the largest institutional shareholder, holding 9.78% of NRXP shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 1.36% of its assets in NRx Pharmaceuticals shares.
NRXP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NRx Pharmaceuticals | 18.25% | 15.88% | 65.87% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Anson funds management lp | 1.60M | 9.78% | $5.23M |
| Vanguard group | 534.96K | 2.98% | $1.77M |
| Advisorshares investments | 342.14K | 1.91% | $1.13M |
| Geode capital management | 185.86K | 1.04% | $613.46K |
| Blackrock funding, inc. /de | 65.41K | 0.36% | $215.86K |
| Chicago partners investment group | 41.99K | 0.23% | $125.98K |
| Marshall wace, llp | 33.38K | 0.20% | $108.83K |
| One wealth management investment & advisory services | 27.99K | 0.16% | $92.37K |
| Ethos financial group | 11.90K | 0.07% | $39.27K |
| Raymond james financial | 2.57K | 0.02% | $8.38K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Anson funds management lp | 1.60M | 0.75% | $5.23M |
| Advisorshares investments | 342.14K | 0.18% | $1.13M |
| One wealth management investment & advisory services | 27.99K | 0.11% | $92.37K |
| Chicago partners investment group | 41.99K | 0.00% | $125.98K |
| Ethos financial group | 11.90K | 0.00% | $39.27K |
| Sbi securities | 2.50K | 0.00% | $8.25K |
| Carolina wealth advisors | 50.00 | 0.00% | $165.00 |
| Marshall wace, llp | 33.38K | 0.00% | $108.83K |
| Jpmorgan chase | 34.00 | - | $112.00 |
| Group one trading | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Anson funds management lp | 1.60M | 0.75% | 425.91K |
| Vanguard group | 534.96K | - | 82.78K |
| Advisorshares investments | 342.14K | 0.18% | 78.34K |
| Chicago partners investment group | 41.99K | 0.00% | 41.99K |
| Geode capital management | 185.86K | - | 13.61K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 33.38K | 0.00% | -55.70K |
| Townsquare capital | - | - | -15.04K |
| Group one trading | - | - | -3.11K |
| Sbi securities | 2.50K | 0.00% | -892.00 |
| Simplex trading | - | - | -690.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Chicago partners investment group | 41.99K | 0.00% | 41.99K | $125.98K |
| Ethos financial group | 11.90K | 0.00% | 11.90K | $39.27K |
| Raymond james financial | 2.57K | - | 2.57K | $8.38K |
Sold Out
| Holder | Change |
|---|---|
| Simplex trading | -690.00 |
| Group one trading | -3.11K |
| Townsquare capital | -15.04K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 25 | 8.70% | 2,994,368 | 32.46% | 18 | 9.62% | 15 | 50.00% | 4 | -33.33% |
| Mar 31, 2025 | 23 | -14.81% | 2,260,524 | 115.57% | 13 | 13.86% | 10 | -37.50% | 6 | 200.00% |
| Dec 31, 2024 | 27 | 28.57% | 1,048,642 | 46.80% | 9 | 23.53% | 16 | 77.78% | 2 | -50.00% |
| Sep 30, 2024 | 21 | - | 714,327 | 39.97% | 6 | 27.64% | 9 | 80.00% | 4 | -73.33% |
| Jun 30, 2024 | 21 | -34.38% | 510,359 | -86.33% | 4 | 27.29% | 5 | -37.50% | 15 | 87.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AdvisorShares Psychedelics ETF | 323.15K | 1.36% | - |
| Vanguard Total Stock Mkt Idx Inv | 246.38K | 1.26% | -5.38K |
| Vanguard US Total Market Shares ETF | 193.42K | 1.23% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 144.48K | 0.74% | -41.40K |
| Fidelity Extended Market Index | 74.11K | 0.31% | -609.00 |
| KoAct US Brain Treatment Active | 41.02K | 0.26% | 41.02K |
| iShares Micro-Cap ETF | 32.09K | 0.14% | - |
| Fidelity Total Market Index | 31.03K | 0.13% | -66.00 |
| Spartan Extended Market Index Pool E | 14.99K | 0.10% | 6.13K |
| Fidelity Nasdaq Composite Index | 21.98K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 17, 2024 | Javitt Jonathan C | Chairman and Chief Scientist | Buy | $46.80K |
| Aug 30, 2023 | Gorovitz Aaron | - | Buy | $11.20K |
| Aug 30, 2023 | Hurvitz Chaim | - | Buy | $20.13K |
| Aug 23, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $33.00K |
| Aug 22, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $64.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 1 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 4 | - |
NRXP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools